Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Brenner

Showing results (161-170 of 219) with videos related to

Pageof 22
Sort By:
Retrovirology|August 19, 2018
Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravirMaureen Oliveira, Ruxandra-Ilinca Ibanescu, Kaitlin Anstett, et al.
Plos One|June 10, 2011
A template-dependent dislocation mechanism potentiates K65R reverse transcriptase mutation development in subtype C variants of HIV-1Dimitrios Coutsinos, Cédric F Invernizzi, Daniela Moisi, et al.
Antimicrobial Agents and Chemotherapy|December 10, 2008
Nucleoside and nucleotide analogs select in culture for different patterns of drug resistance in human immunodeficiency virus types 1 and 2Michel L Ntemgwa, Thomas d'Aquin Toni, Bluma G Brenner, et al.
Journal of Virology|August 19, 2011
Compensation by the E138K mutation in HIV-1 reverse transcriptase for deficits in viral replication capacity and enzyme processivity associated with the M184I/V mutationsHong-Tao Xu, Eugene L Asahchop, Maureen Oliveira, et al.
Antimicrobial Agents and Chemotherapy|December 8, 2010
Characterization of the E138K resistance mutation in HIV-1 reverse transcriptase conferring susceptibility to etravirine in B and non-B HIV-1 subtypesEugene L Asahchop, Maureen Oliveira, Mark A Wainberg, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2009
Detection of human immunodeficiency virus (HIV) type 1 M184V and K103N minority variants in patients with primary HIV infectionThomas A Toni, Eugene L Asahchop, Daniela Moisi, et al.
AIDS (London, England)|December 25, 2012
Distinct resistance patterns to etravirine and rilpivirine in viruses containing nonnucleoside reverse transcriptase inhibitor mutations at baselineEugene L Asahchop, Mark A Wainberg, Maureen Oliveira, et al.
Journal of Virology|May 25, 2012
Subunit-selective mutational analysis and tissue culture evaluations of the interactions of the E138K and M184I mutations in HIV-1 reverse transcriptaseHong-Tao Xu, Maureen Oliveira, Peter K Quashie, et al.
AIDS (London, England)|July 4, 2006
HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell cultureBluma G Brenner, Maureen Oliveira, Florence Doualla-Bell, et al.
British Journal of Pharmacology|April 16, 1999
Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetilM Shipkova, V W Armstrong, E Wieland, et al.
Pageof 22

Showing results (161-170 of 219) with videos related to

Sort By:
Pageof 22
Retrovirology|August 19, 2018
Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravirMaureen Oliveira, Ruxandra-Ilinca Ibanescu, Kaitlin Anstett, et al.
Plos One|June 10, 2011
A template-dependent dislocation mechanism potentiates K65R reverse transcriptase mutation development in subtype C variants of HIV-1Dimitrios Coutsinos, Cédric F Invernizzi, Daniela Moisi, et al.
Antimicrobial Agents and Chemotherapy|December 10, 2008
Nucleoside and nucleotide analogs select in culture for different patterns of drug resistance in human immunodeficiency virus types 1 and 2Michel L Ntemgwa, Thomas d'Aquin Toni, Bluma G Brenner, et al.
Journal of Virology|August 19, 2011
Compensation by the E138K mutation in HIV-1 reverse transcriptase for deficits in viral replication capacity and enzyme processivity associated with the M184I/V mutationsHong-Tao Xu, Eugene L Asahchop, Maureen Oliveira, et al.
Antimicrobial Agents and Chemotherapy|December 8, 2010
Characterization of the E138K resistance mutation in HIV-1 reverse transcriptase conferring susceptibility to etravirine in B and non-B HIV-1 subtypesEugene L Asahchop, Maureen Oliveira, Mark A Wainberg, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2009
Detection of human immunodeficiency virus (HIV) type 1 M184V and K103N minority variants in patients with primary HIV infectionThomas A Toni, Eugene L Asahchop, Daniela Moisi, et al.
AIDS (London, England)|December 25, 2012
Distinct resistance patterns to etravirine and rilpivirine in viruses containing nonnucleoside reverse transcriptase inhibitor mutations at baselineEugene L Asahchop, Mark A Wainberg, Maureen Oliveira, et al.
Journal of Virology|May 25, 2012
Subunit-selective mutational analysis and tissue culture evaluations of the interactions of the E138K and M184I mutations in HIV-1 reverse transcriptaseHong-Tao Xu, Maureen Oliveira, Peter K Quashie, et al.
AIDS (London, England)|July 4, 2006
HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell cultureBluma G Brenner, Maureen Oliveira, Florence Doualla-Bell, et al.
British Journal of Pharmacology|April 16, 1999
Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetilM Shipkova, V W Armstrong, E Wieland, et al.
Pageof 22